These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 8733040)
1. Decreased blood viscosity and serum levels of erythropoietin after anti-hypertensive treatment with amlodipine or metoprolol: results of a cross-over study. Linde T; Sandhagen B; Hägg A; Mörlin C; Danielson BG J Hum Hypertens; 1996 Mar; 10(3):199-205. PubMed ID: 8733040 [TBL] [Abstract][Full Text] [Related]
2. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related]
3. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy. Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177 [TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy. Ibrahim MM; el-Boghdadly B; Zaghloul SS J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565 [TBL] [Abstract][Full Text] [Related]
5. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
6. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients. Celik T; Iyisoy A; Kursaklioglu H; Kardesoglu E; Kilic S; Turhan H; Yilmaz MI; Ozcan O; Yaman H; Isik E; Fici F J Hypertens; 2006 Mar; 24(3):591-6. PubMed ID: 16467663 [TBL] [Abstract][Full Text] [Related]
9. Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy. Nadar S; Blann AD; Lip GY Ann Med; 2004; 36(7):552-7. PubMed ID: 15513305 [TBL] [Abstract][Full Text] [Related]
10. Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity. Aksnes TA; Seljeflot I; Torjesen PA; Höieggen A; Moan A; Kjeldsen SE Metabolism; 2007 Nov; 56(11):1470-7. PubMed ID: 17950096 [TBL] [Abstract][Full Text] [Related]
11. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment. Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of AT1 inhibition and Ca2+-channel blockade in hypertensive patients during isometric stress. Arosio E; De Marchi S; Prior M; Rigoni A; Lechi A J Hum Hypertens; 2006 Mar; 20(3):201-5. PubMed ID: 16319906 [TBL] [Abstract][Full Text] [Related]
14. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension. Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Murakami K; Higaki J Clin Ther; 2006 Oct; 28(10):1677-85. PubMed ID: 17157123 [TBL] [Abstract][Full Text] [Related]
15. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
16. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients? Ruzicka M; Coletta E; Leenen FH Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368 [TBL] [Abstract][Full Text] [Related]
17. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison. Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY; Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979 [TBL] [Abstract][Full Text] [Related]
18. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123 [TBL] [Abstract][Full Text] [Related]
19. Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension. Beltman FW; Heesen WF; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Lie KI; Meyboom-de Jong B Blood Press; 1998 May; 7(2):109-17. PubMed ID: 9657538 [TBL] [Abstract][Full Text] [Related]
20. Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients. Naya M; Tsukamoto T; Morita K; Katoh C; Furumoto T; Fujii S; Tamaki N; Tsutsui H J Am Coll Cardiol; 2007 Sep; 50(12):1144-9. PubMed ID: 17868805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]